Literature DB >> 27809971

Vaccination of goats against Haemonchus contortus with the gut membrane proteins H11/H-gal-GP.

Lorena Meier1, Paul R Torgerson2, Hubertus Hertzberg3.   

Abstract

Forty goats, aged from 2 to 5 months were subjected to two different immunization protocols with a vaccine containing Haemonchus contortus gut membrane proteins H11/H-gal-GP to evaluate protection against H. contortus on pre-contaminated pastures. Goats were allocated to four groups of ten, three of them received their first vaccination before turnout. One group (V4) was then vaccinated at 4-week-intervals whereas another two groups (V6 and V6SEP) were vaccinated at 6-week-intervals. A control group (CTRL) remained unvaccinated. In May, after the second vaccination, all goats were turned out on pastures which had been previously contaminated with H. contortus eggs by seeder sheep for a period of six weeks. Goats of groups V4, V6 and CTRL were grazed together, whereas V6SEP was kept separately at an identical stocking rate. Clinical (PCV, FAMACHA, body weight), parasitological (faecal egg count, FEC) and serological (antibody titres) parameters were measured fortnightly. All goats were stabled in October, drenched with levamisole and two weeks later infected with 5000 L3 of H. contortus and slaughtered four weeks later for determination of abomasal worm burdens. Group mean FEC peaked 42-56days after turnout. Significantly lower FEC were observed in V6SEP vs CTRL between D 28 and 70 (p<0.01). Mean egg output of all groups decreased substantially and fluctuated at low levels until the end of the grazing period (D 154). Goats responded to vaccination with increasing antibody titres peaking after every booster. Mean worm burdens deriving from experimental infections were reduced by 89, 65 and 47% in groups V4, V6 and V6SEP, respectively, compared with the controls. The difference was significant for V4 (p<0.01). Antibody titres measured 14days before slaughter did not correlate statistically with the worm burdens. It was concluded that the vaccination protocol did not result in sufficient protection on pasture, as antibody titres were still low at the time the goats were exposed to larval contamination on pasture after turnout.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Control; Field study; Goats; Haemonchus contortus; Vaccination

Mesh:

Substances:

Year:  2016        PMID: 27809971     DOI: 10.1016/j.vetpar.2016.08.024

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Probing the opportunities for designing anthelmintic leads by sub-structural topology-based QSAR modelling.

Authors:  Prabodh Ranjan; Mohd Athar; Prakash Chandra Jha; Kari Vijaya Krishna
Journal:  Mol Divers       Date:  2018-04-02       Impact factor: 2.943

2.  Vaccination of lambs against Haemonchus contortus with the recombinant rHc23. Effect of adjuvant and antigen dose.

Authors:  María Elena González-Sánchez; Montserrat Cuquerella; José M Alunda
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

3.  Immunization of Goats with Recombinant Protein 14-3-3 Isoform 2(rHcftt-2) Induced Moderate Protection against Haemonchus contortus Challenge.

Authors:  Yongqian Bu; Caiwen Jia; Xiaowei Tian; Kalibixiati Aimulajiang; Muhammad Ali Memon; Ruofeng Yan; Xiaokai Song; Lixin Xu; Xiangrui Li
Journal:  Pathogens       Date:  2020-01-06

Review 4.  Helminth Vaccines in Ruminants: From Development to Application.

Authors:  Edwin Claerebout; Peter Geldhof
Journal:  Vet Clin North Am Food Anim Pract       Date:  2020-03       Impact factor: 3.357

5.  Vaccination against the brown stomach worm, Teladorsagia circumcincta, followed by parasite challenge, induces inconsistent modifications in gut microbiota composition of lambs.

Authors:  Alba Cortés; Riccardo Scotti; James Rooney; Daniel R G Price; Yvonne Bartley; Karen Fairlie-Clarke; Tom N McNeilly; Alasdair J Nisbet; Cinzia Cantacessi
Journal:  Parasit Vectors       Date:  2021-04-06       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.